Novadip Biosciences
Late-stage clinical BioTech company specializing in regenerative medicine.
Novadip Biosciences is a biotech & life sciences company based in BE, founded in 2013. It has raised $11.95 million in disclosed funding. Its latest round was an Undisclosed stage of €10.4 million in September 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $11.9M across 1 round. Computed only from sourced rounds.
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| €10.4M | Undisclosed stage | New Science Ventures | Fund+ +6 | Biotech & Life Sciences | 1 |
- Novadip Biosciences€10.4M
Led by New Science Ventures · with Fund+, +6
Investors
Questions and answers
What does Novadip Biosciences do?
Late-stage clinical BioTech company specializing in regenerative medicine.
How much has Novadip Biosciences raised?
Novadip Biosciences has raised $11.95 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Novadip Biosciences?
Investors in Novadip Biosciences include New Science Ventures, Fund+, Wallonie Entreprendre, VIVES Fund, ORSA Tech and 3 more.
When and where was Novadip Biosciences founded?
Novadip Biosciences was founded in 2013 and is based in BE.
Timeline
Founded
Sources
- 1.Belgium’s Novadip Biosciences raises €10.4 million to fund pivotal clinical trial and unlock EIB loan tranche — EU-Startups, Sep 21, 2026